Table 1.

Clinical characteristics of patients with testicular germ cell tumours

	n	%	Age
			min	median (IQR)	max
All GCT	422	100	14	36 (31–45)	74
Seminoma	254	60.2	17	41 (34–47)	66
Nonseminoma	168	39.8	14	31 (26–37.5)	74
pT1	222	52.6	17	37 (32–44)	74
>pT1	200	47.4	14	36 (29–45)	66
CS1 (all GCT)	281	66.6	17	38 (32–45)	74
CS2a, b	95	22.5	14	33 (27–44)	66
CS2c	17	4.0	20	36 (31–42)	59
CS3	29	6.9	17	34 (25–44)	55
CS1 (seminoma)	201	79.1	17	40 (34–46)	64
CS2a, b	37	14.6	26	42 (32–47)	66
CS2c	9	3.5	35	42 (36–46)	59
CS3	7	2.8	31	45 (31–48)	55
CS1 (nonseminoma)	80	47.6	17	32 (27–38)	74
CS2a, b	58	34.5	14	29 (26–37)	53
CS2c	8	4.8	20	29.5 (22.5–34)	44
CS3	22	13.1	17	33 (22–42)	51
NS with teratoma	80	47.6	17	31 (24–35.5)	74
No teratoma	88	52.4	14	31 (27–39)	64
<25% teratoma	18	10.7	20	31.5 (26–36)	53
>25–≤50% teratoma	25	14.9	17	34 (27–38)	74
>50–≤75% teratoma	13	7.7	18	27 (22–34)	51
>75% teratoma	24	14.3	17	28 (22–33.5)	58
Tumour on right side	201	47.6	14	37 (32–45)	66
Left side	200	47.4	17	36 (29–44.5)	74
Bilateral synchronously	9	2.1	17	33 (30–36)	47
Bilateral sequential	6	1.4	23	34 (28–39)	44
Extragonadal	4	0.9	47	52 (47–57)	57

GCT, germ cell tumour; CS, clinical stages; IQR, interquartile range; pT, pathological; NS, nonseminoma.